Effect of plant-based diets on obesity-related inflammatory profiles: a systematic review and meta-analysis of intervention trials

Obesity Reviews

Volumn 17, Issue 11, 2016, Pages 1067-1079

  Eichelmann, F ^a   Schwingshackl, L ^a   Fedirko, V ^b   Aleksandrova, K ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b EMORY UNIVERSITY   (United States)

Author keywords

Adipose tissue inflammation; chronic disease; metabolic dysfunction; plant based diets; prevention

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEPTIN; RESISTIN; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL (TOPIC); DIET; DIET THERAPY; HUMAN; INFLAMMATORY DISEASE; META ANALYSIS; OBESITY; PLANT BASED DIET; REVIEW; SYSTEMATIC REVIEW;

EID: 84990858952     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12439     Document Type: Review

References (73)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860–67.
2. Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 743–800.
3. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 2016; 133: 187–225.
4. Barbaresko J, Koch M, Schulze MB, Nothlings U. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutrition Reviews 2013; 71: 511–27.
5. Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. American Journal of Clinical Nutrition 2003; 78: 544S–51S.
6. Trichopoulou A, Martinez-Gonzalez MA, Tong TY et al. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Medicine 2014; 12: 112.
7. Kanerva N, Rissanen H, Knekt P, Havulinna AS, Eriksson JG, Mannisto S. The healthy Nordic diet and incidence of Type 2 Diabetes—10-year follow-up. Diabetes Research and Clinical Practice 2014; 106: e34–7.
8. Rifai L, Silver MA. A review of the DASH diet as an optimal dietary plan for symptomatic heart failure. Progress in Cardiovascular Diseases 2015; 58: 548–554.
9. Higgins JPT GSe. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. In: Collaboration TC (ed.): 2011.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–60.
11. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–34.
12. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Statistics in Medicine 2007; 26: 4544–62.
13. Schwarzer G. meta: General Package for Meta-Analysis. R package version 4.3-0.: 2015.
14. Hunter P. The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Reports 2012; 13: 968–70.
15. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circulation Journal 2011; 75: 2739–48.
16. Prasad S, Sung B, Aggarwal BB. Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Preventive Medicine 2012; 54(Suppl): S29–37.
17. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2014; 69(Suppl 1): S4–9.
18. Rosner MH, Ronco C, Okusa MD. The role of inflammation in the cardio-renal syndrome: a focus on cytokines and inflammatory mediators. Seminars in Nephrology 2012; 32: 70–8.
19. Grunfeld C, Feingold KR. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 1991; 3: 143–58.
20. Reilly MP, Rohatgi A, McMahon K et al. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. Journal of Investigative Medicine 2007; 55: 26–35.
21. Ekstrom M, Soderberg S, Tornvall P. Acute systemic inflammation is unlikely to affect adiponectin and leptin synthesis in humans. Front Cardiovasc Med. 2015; 2: 7.
22. Scotece M, Conde J, Lopez V et al. Adiponectin and leptin: new targets in inflammation. Basic and Clinical Pharmacology and Toxicology 2014; 114: 97–102.
23. Dalamaga M. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives. Biomarkers in Medicine 2014; 8: 107–18.
24. van Stijn CM, Kim J, Barish GD, Tietge UJ, Tangirala RK. Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS One 2014; 9: e86404.
25. Chakraborti CK. Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity. World J Diabetes. 2015; 6: 1296–308.
26. Piestrzeniewicz K, Luczak K, Komorowski J et al. Obesity and adiponectin in acute myocardial infarction. Cardiology Journal 2007; 14: 29–36.
27. Aprahamian TR, Sam F. Adiponectin in cardiovascular inflammation and obesity. Int J Inflam. 2011; 2011 376909.
28. Aleksandrova K, Boeing H, Jenab M et al. Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. Carcinogenesis 2012; 33: 1211–8.
29. Vavruch C, Lanne T, Fredrikson M, Lindstrom T, Ostgren CJ, Nystrom FH. Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes. Cardiovascular Diabetology 2015; 14: 62.
30. Moreno LO, Salvemini L, Mendonca C et al. Serum resistin and glomerular filtration rate in patients with type 2 diabetes. PLoS One 2015; 10 e0119529.
31. Lee K, Song YM, Sung J. Genetic and environmental associations between C-reactive protein and components of the metabolic syndrome. Metabolic Syndrome and Related Disorders 2013; 11: 136–42.
32. Musani SK, Vasan RS, Bidulescu A et al. Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study. Diabetes Care 2013; 36: 3084–92.
33. Zou S, Pan X, Chen Z, Wei C, He B, Zhang H. Intercellular adhesion molecule-1 K469E polymorphism and risk of coronary artery disease: a meta-analysis. Med Sci Monit 2014; 20: 2677–82.
34. Kamiuchi K, Hasegawa G, Obayashi H et al. Intercellular adhesion molecule-1 (ICAM-1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus. Diabetic Medicine 2002; 19: 371–6.
35. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. Journal of the American College of Cardiology 2006; 48: 677–85.
36. Ostan R, Lanzarini C, Pini E et al. Inflammaging and cancer: a challenge for the Mediterranean diet. Nutrients. 2015; 7: 2589–621.
37. A comprehensive meta-analysis on evidence of mediterranean diet and cardiovascular disease: are individual components equal?
38. Akesson A, Andersen LF, Kristjansdottir AG et al. Health effects associated with foods characteristic of the Nordic diet: a systematic literature review. Food Nutr Res. 2013; 57.
39. Urpi-Sarda M, Casas R, Chiva-Blanch G et al. The Mediterranean diet pattern and its main components are associated with lower plasma concentrations of tumor necrosis factor receptor 60 in patients at high risk for cardiovascular disease. The Journal of Nutrition 2012; 142: 1019–25.
40. Esposito K, Marfella R, Ciotola M et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292(12): 1440–6.
41. Luscher TF. Ageing, inflammation, and oxidative stress: final common pathways of cardiovascular disease. European Heart Journal 2015; 36: 3381–3.
42. Nassar AL, Marot LP, Ovidio PP, Castro GS, Jordao AA Jr. Oxidative stress and fatty acid profile in Wistar rats subjected to acute food restriction and refeeding with high-fat diets. Acta Cirúrgica Brasileira 2014; 29: 178–85.
43. Qi L, Hu FB. Dietary glycemic load, whole grains, and systemic inflammation in diabetes: the epidemiological evidence. Current Opinion in Lipidology 2007; 18: 3–8.
44. Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: a systematic review and meta-analysis. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2013; 23: 699–706.
45. Schwingshackl L, Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2014; 24: 929–39.
46. Shai I, Schwarzfuchs D, Henkin Y et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. New England Journal of Medicine 2008; 359: 229–41.
47. Asemi Z, Esmaillzadeh A. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Hormone and metabolic research 2015; 47: 232–8.
48. Athyros VG, Kakafika AI, Papageorgiou AA et al. Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutr Metab Cardiovasc Dis 2011; 21: 213–21.
49. Azadbakht L, Surkan PJ, Esmaillzadeh A, Willett WC. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. Journal of Nutrition 2011; 141(6): 1083–1088.
50. Bladbjerg E-M, Larsen TM, Due A, Stender S, Astrup A, Jespersen J. Effects on markers of inflammation and endothelial cell function of three ad libitum diets differing in type and amount of fat and carbohydrate: a 6-month randomised study in obese individuals. British Journal of Nutrition 2011; 106(1): 123–9.
51. Casas R, Sacanella E, Urpi-Sarda M et al. The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS One 2014; 9: e100084.
52. Ceriello A, Esposito K, La Sala L et al. The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report. Cardiovascular Diabetology 2014; 13: 140.
53. de Mello VD, Schwab U, Kolehmainen M et al. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia 2011; 54: 2755–67.
54. Djuric Z, Ren J, Blythe J, VanLoon G, Sen A. A Mediterranean dietary intervention in healthy American women changes plasma carotenoids and fatty acids in distinct clusters. Nutrition research (New York, NY) 2009; 29: 156–63.
55. Esposito K, Marfella R, Ciotola M et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440–6.
56. Esposito K, Maiorino MI, Ciotola M et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Annals of Internal Medicine 2009; 151: 306–14.
57. Itsiopoulos C, Brazionis L, Kaimakamis M et al. Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study. Nutrition, Metabolism, and Cardiovascular Diseases 2011; 21: 740–7.
58. Jonsson T, Granfeldt Y, Ahren B et al. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovascular Diabetology 2009; 8: 35.
59. Kahleova H, Matoulek M, Malinska H et al. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabetic Medicine 2011; 28: 549–59.
60. Konstantinidou V, Covas MI, Munoz-Aguayo D et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2010; 24: 2546–57.
61. Lasa A, Miranda J, Bullo M et al. Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes. European Journal of Clinical Nutrition 2014; 68: 767–72.
62. Maiorino MI, Bellastella G, Petrizzo M, Scappaticcio L, Giugliano D, Esposito K. Mediterranean diet cools down the inflammatory milieu in type 2 diabetes: the MEDITA randomized controlled trial. Endocrine 2016; [Epub ahead of print].
63. Mekki K, Bouzidi-bekada N, Kaddous A, Bouchenak M. Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients. Food & Function 2010; 1: 110–5.
64. Poulsen SK, Due A, Jordy AB et al. Health effect of the New Nordic Diet in adults with increased waist circumference: a 6-mo randomized controlled trial. American Journal of Clinical Nutrition 2014; 99: 35–45.
65. Richard C, Couture P, Desroches S, Lamarche B. Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome. Obesity (Silver Spring, Md) 2013; 21: 51–7.
66. Richard C, Royer MM, Couture P et al. Effect of the Mediterranean diet on plasma adipokine concentrations in men with metabolic syndrome. Metabolism 2013; 62: 1803–10.
67. Rokling-Andersen MH, Reseland JE, Veierod MB et al. Effects of long-term exercise and diet intervention on plasma adipokine concentrations. The American Journal of Clinical Nutrition 2007; 86: 1293–301.
68. Sexton P, Black P, Metcalf P et al. Influence of mediterranean diet on asthma symptoms, lung function, and systemic inflammation: a randomized controlled trial. The Journal of Asthma: Official Journal of the Association for the Care of Asthma. 2013; 50: 75–81.
69. Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2003; 62: 208–14.
70. Stachowska E, Wesolowska T, Olszewska M et al. Elements of Mediterranean diet improve oxidative status in blood of kidney graft recipients. The British Journal of Nutrition 2005; 93: 345–52.
71. Thomazella MC, Goes MF, Andrade CR et al. Effects of high adherence to mediterranean or low-fat diets in medicated secondary prevention patients. The American Journal of Cardiology 2011; 108: 1523–9.
72. Tuttle KR, Shuler LA, Packard DP et al. Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial). American Journal of Cardiolology 2008; 101: 1523–30.
73. Uusitupa M, Hermansen K, Savolainen MJ et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome—a randomized study (SYSDIET). Journal of Internal Medicine 2013; 274: 52–66.